Sime Armoyan - Net Worth and Insider Trading

Sime Armoyan Net Worth

The estimated net worth of Sime Armoyan is at least $535 Million dollars as of 2024-05-21. Sime Armoyan is the 10% Security Holder of Clarke Inc and owns about 10,599,001 shares of Clarke Inc (TSX:CKI) stock worth over $199 Million. Sime Armoyan is the 10% Security Holder of Morguard Corp and owns about 1,121,327 shares of Morguard Corp (TSX:MRC) stock worth over $125 Million. Sime Armoyan is also the 10% Security Holder of Calfrac Well Services Ltd and owns about 28,239,729 shares of Calfrac Well Services Ltd (TSX:CFW) stock worth over $116 Million. Besides these, Sime Armoyan also holds Knight Therapeutics Inc (TSX:GUD) , Western Energy Services Corp (TSX:WRG) . Details can be seen in Sime Armoyan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sime Armoyan has not made any transactions after 2024-05-14 and currently still holds the listed stock(s).

Transaction Summary of Sime Armoyan

To

Sime Armoyan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sime Armoyan owns 3 companies in total, including Knight Therapeutics Inc (TSX:GUD) , Morguard Corp (TSX:MRC) , and Western Energy Services Corp (TSX:WRG) .

Click here to see the complete history of Sime Armoyan’s form 4 insider trades.

Insider Ownership Summary of Sime Armoyan

Ticker Comapny Transaction Date Type of Owner
TSX:GUD Knight Therapeutics Inc 2024-04-11 10% Security Holder
TSX:MRC Morguard Corp 2024-05-03 10% Security Holder
TSX:WRG Western Energy Services Corp 2024-04-30 10% Security Holder

Sime Armoyan Latest Holdings Summary

Sime Armoyan currently owns a total of 5 stocks. Among these stocks, Sime Armoyan owns 10,599,001 shares of Clarke Inc (TSX:CKI) as of March 22, 2024, with a value of $199 Million and a weighting of 37.23%. Sime Armoyan owns 1,121,327 shares of Morguard Corp (TSX:MRC) as of May 14, 2024, with a value of $125 Million and a weighting of 23.44%. Sime Armoyan also owns 28,239,729 shares of Calfrac Well Services Ltd (TSX:CFW) as of December 13, 2023, with a value of $116 Million and a weighting of 21.63%. The other 2 stocks Knight Therapeutics Inc (TSX:GUD) , Western Energy Services Corp (TSX:WRG) have a combined weighting of 17.69% among all his current holdings.

Latest Holdings of Sime Armoyan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:CKI Clarke Inc 2024-03-22 10,599,001 18.80 199,261,219
TSX:MRC Morguard Corp 2024-05-14 1,121,327 111.90 125,476,491
TSX:CFW Calfrac Well Services Ltd 2023-12-13 28,239,729 4.10 115,782,889
TSX:GUD Knight Therapeutics Inc 2024-05-09 12,666,200 6.11 77,390,482
TSX:WRG Western Energy Services Corp 2024-05-14 6,366,956 2.72 17,318,120

Holding Weightings of Sime Armoyan


Sime Armoyan Form 4 Trading Tracker

According to the SEC Form 4 filings, Sime Armoyan has made a total of 19 transactions in Clarke Inc (TSX:CKI) over the past 5 years, including 15 buys and 4 sells. The most-recent trade in Clarke Inc is the sale of 500 shares on March 22, 2024, which brought Sime Armoyan around $9,750.

According to the SEC Form 4 filings, Sime Armoyan has made a total of 25 transactions in Morguard Corp (TSX:MRC) over the past 5 years, including 25 buys and 0 sells. The most-recent trade in Morguard Corp is the acquisition of 300 shares on May 14, 2024, which cost Sime Armoyan around $33,299.

According to the SEC Form 4 filings, Sime Armoyan has made a total of 1 transactions in Calfrac Well Services Ltd (TSX:CFW) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Calfrac Well Services Ltd is the acquisition of 11,700 shares on December 13, 2023, which cost Sime Armoyan around $47,000.

More details on Sime Armoyan's insider transactions can be found in the Insider Trading History of Sime Armoyan table.

Insider Trading History of Sime Armoyan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sime Armoyan Trading Performance

GuruFocus tracks the stock performance after each of Sime Armoyan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sime Armoyan is %. GuruFocus also compares Sime Armoyan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sime Armoyan within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sime Armoyan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sime Armoyan

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.07
Relative Return to S&P 500(%) 4.57

Sime Armoyan Ownership Network

Ownership Network List of Sime Armoyan

No Data

Ownership Network Relation of Sime Armoyan


Sime Armoyan Owned Company Details

What does Knight Therapeutics Inc do?

Who are the key executives at Knight Therapeutics Inc?

Sime Armoyan is the 10% Security Holder of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include and Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman .

Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary

Over the past 18 months, Sime Armoyan made 26 insider transaction in Knight Therapeutics Inc (TSX:GUD) with a net purchase of 674,800. Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 25,000 shares made by Jonathan Ross Goodman ,

In summary, during the past 3 months, insiders sold 85,000 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 500,600 shares, with a net purchase of 415,600 shares. During the past 18 months, 204,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 904,000 shares were bought by its insiders, resulting in a net purchase of 699,800 shares.

Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Knight Therapeutics Inc Insider Transactions

No Available Data

Sime Armoyan Mailing Address

Above is the net worth, insider trading, and ownership report for Sime Armoyan. Currently GuruFocus does not have mailing address information for Sime Armoyan.

Discussions on Sime Armoyan

No discussions yet.